Apomorphine protects against MPTP-induced neurotoxicity in mice (Q48144127)

9 February 2018

title

Apomorphine protects against MPTP-induced neurotoxicity in mice (English)

1 reference

9 February 2018

1 reference

1 reference

1 reference

1

1 reference

9 February 2018

Silvia A. Mandel

series ordinal

2

object named as

Mandel S

1 reference

9 February 2018

author name string

Berkuzki T

series ordinal

3

1 reference

9 February 2018

Youdim MB

series ordinal

4

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 July 1999

1 reference

9 February 2018

published in

Movement Disorders

1 reference

9 February 2018

volume

14

1 reference

9 February 2018

issue

4

1 reference

9 February 2018

page(s)

612-618

1 reference

9 February 2018

The possible role of iron in the etiopathology of Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Dopamine agonists in Parkinson's disease: a look at apomorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Oxidative stress and antioxidant therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Increased efflux rather than oxidation is the mechanism of glutathione depletion by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

RADIOISOTOPIC ASSAY FOR MONOAMINE OXIDASE DETERMINATIONS IN HUMAN PLASMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Apomorphine infusional therapy in Parkinson's disease: clinical utility and lack of tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Apomorphine Is a Potent Radical Scavenger and Protects Cultured Pheochromocytoma Cells from 6-OHDA and H2O2-Induced Cell Death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Antioxidant properties of bromocriptine, a dopamine agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Neuroprotective effect of the iron chelator desferrioxamine against MPP+ toxicity on striatal dopaminergic terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Nature of inhibition of mitochondrial respiratory complex I by 6-Hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Mechanism of 6-hydroxydopamine neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Free radical scavenging properties of apomorphine enantiomers and dopamine: possible implication in their mechanism of action in parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Apomorphine pharmacokinetics in Parkinsonism after intranasal and subcutaneous application

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C612%3A%3AAID-MDS1010%3E3.0.CO%3B2-6

10.1002/1531-8257(199907)14:4<612::AID-MDS1010>3.0.CO;2-6

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

release_3da5b237mjbbldxi7xr4y7x6vm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3da5b237mjbbldxi7xr4y7x6vm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

9 February 2018